Patents by Inventor Lars Anders Svensson

Lars Anders Svensson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Humanized antibodies against human interferon-alpha
    Patent number: 8658771
    Abstract: The present invention provides humanized anti-human IFN-? monoclonal antibodies useful for therapeutic applications in humans. Preferred antibodies are humanized versions of murine antibodies ACO-1 and ACO-2, as well as variants thereof.
    Type: Grant
    Filed: December 19, 2012
    Date of Patent: February 25, 2014
    Assignee: Argos Therapeutics, Inc.
    Inventors: Lars Anders Svensson, Soren Padkjaer, Birgitte Friedrichsen, Berit Olsen Krogh, Inger Lund Pedersen, Jan Fleckner
  • IL-21 LIGANDS
    Publication number: 20130323259
    Abstract: The present invention relates to IL-21 ligands binding to a discontinuous epitope on the surface of the IL-21 molecule as well as use thereof.
    Type: Application
    Filed: January 17, 2012
    Publication date: December 5, 2013
    Applicant: Novo Nordisk A/S
    Inventors: Lars Anders Svensson, Mette Dahl Andersen, Jens Breinholt, Charlotte Wiberg, Berit Olsen Krogh, Dorthe Lundsgaard, Hanne Benedicte Rasmussen
  • Humanized Antibodies Against Human Interferon-Alpha
    Publication number: 20130101602
    Abstract: The present invention provides humanized anti-human IFN-? monoclonal antibodies useful for therapeutic applications in humans. Preferred antibodies are humanized versions of murine antibodies ACO-1 and ACO-2, as well as variants thereof.
    Type: Application
    Filed: December 19, 2012
    Publication date: April 25, 2013
    Applicant: ARGOS THERAPEUTICS, INC.
    Inventors: Lars Anders Svensson, Soren Padkjaer, Birgitte Friedrichsen, Berit Olsen Krogh, Inger Lund Pedersen
  • Humanized antibodies against human interferon-alpha
    Patent number: 8361463
    Abstract: The present invention provides humanized anti-human IFN-? monoclonal antibodies useful for therapeutic applications in humans. Preferred antibodies are humanized versions of murine antibodies ACO-1 and ACO-2, as well as variants thereof.
    Type: Grant
    Filed: February 1, 2012
    Date of Patent: January 29, 2013
    Assignee: Argos Therapeutics, Inc.
    Inventors: Lars Anders Svensson, Soren Padkjaer, Birgitte Friedrichsen, Berit Olsen Krogh, Inger Lund Pedersen
  • Humanized Antibodies Against Human Interferon-Alpha
    Publication number: 20120195888
    Abstract: The present invention provides humanized anti-human IFN-? monoclonal antibodies useful for therapeutic applications in humans. Preferred antibodies are humanized versions of murine antibodies ACO-1 and ACO-2, as well as variants thereof.
    Type: Application
    Filed: February 1, 2012
    Publication date: August 2, 2012
    Applicant: NOVO NORDISK A/S
    Inventors: Lars Anders Svensson, Soren Padkjaer, Birgitte Friedrichsen, Berit Olsen Krogh, Inger Lund Pedersen
  • Humanized antibodies against human interferon-alpha
    Patent number: 8163885
    Abstract: The present invention provides humanized anti-human IFN-? monoclonal antibodies useful for therapeutic applications in humans. Preferred antibodies are humanized versions of murine antibodies ACO-1 and ACO-2, as well as variants thereof.
    Type: Grant
    Filed: May 6, 2009
    Date of Patent: April 24, 2012
    Assignee: Argos Therapeutics, Inc.
    Inventors: Lars Anders Svensson, Soren Padkjaer, Birgitte Friedrichsen, Berit Olsen Krogh, Inger Lund Pedersen
  • Humanized Antibodies Against Human Interferon-Alpha
    Publication number: 20110213125
    Abstract: The present invention provides humanized anti-human IFN-? monoclonal antibodies useful for therapeutic applications in humans. Preferred antibodies are humanized versions of murine antibodies ACO-1 and ACO-2, as well as variants thereof.
    Type: Application
    Filed: May 6, 2009
    Publication date: September 1, 2011
    Applicant: Novo Nordisk A/S
    Inventors: Lars Anders Svensson, Soren Padkjaer, Birgitte Friedrichsen, Berit Olsen Krogh, Inger Lund Pedersen